Related Experiment Video
Updated: May 21, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes
1Department of Pathology, University of Alabama at Birmingham, 1670 University Blvd., VH-G019, Birmingham, AL 35294-0019, USA. DHurst@uab.edu
Abstract:
Epigenetic regulation of gene transcription by histone modification and chromatin remodeling has been linked to many biological and pathological events including cancer metastasis. Breast cancer metastasis suppressor 1 (BRMS1) interacts with SIN3 chromatin remodeling complexes, and, upon forced expression in metastatic cells, a nearly complete suppression of metastasis is noted without preventing primary tumor growth. The data for BRMS1-mediated metastasis suppression and SIN3 interaction are clear; however, connecting the inhibition directly to the association of BRMS1 with SIN3 complexes is currently not well defined. Considering the recent advancements in developing epigenetic drugs for cancer therapy, an improved understanding of how the interactions between BRMS1 and SIN3 regulate the process of metastasis should lead to novel therapies specifically targeting the most deadly aspect of tumor progression. In this article, the data for BRMS1-mediated metastasis suppression are reviewed with a focus on how the SIN3 chromatin remodeling complexes may be functionally involved.
Insights
Breast cancer metastasis suppressor 1 (BRMS1) inhibits cancer spread by interacting with SIN3 chromatin remodeling complexes. Understanding this interaction may lead to new epigenetic therapies targeting metastasis.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Epigenetic regulation, including histone modification and chromatin remodeling, influences biological processes and diseases like cancer metastasis.
- Breast cancer metastasis suppressor 1 (BRMS1) is a known suppressor of metastasis that interacts with SIN3 chromatin remodeling complexes.
- While BRMS1 suppresses metastasis and interacts with SIN3, the direct link between this interaction and metastasis inhibition is not fully understood.
Purpose of the Study:
- To review the known data on BRMS1-mediated metastasis suppression.
- To explore the functional involvement of SIN3 chromatin remodeling complexes in BRMS1's metastasis-suppressing activity.
- To highlight the potential for developing novel epigenetic therapies targeting cancer metastasis.
Main Methods:
- Review of existing scientific literature on BRMS1 and SIN3 complex interactions.
- Analysis of data linking BRMS1 expression to metastasis suppression.
- Focus on the role of chromatin remodeling in BRMS1's mechanism of action.
Main Results:
- BRMS1 effectively suppresses breast cancer metastasis upon forced expression.
- BRMS1 interacts with SIN3 chromatin remodeling complexes.
- The precise mechanism connecting BRMS1-SIN3 interaction to metastasis inhibition requires further elucidation.
Conclusions:
- BRMS1 is a potent suppressor of breast cancer metastasis.
- The interaction between BRMS1 and SIN3 complexes is critical for metastasis suppression.
- Further research into this interaction could pave the way for targeted epigenetic therapies against cancer metastasis.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs
MicroRNAs
Inheritance of Chromatin Structures
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
